ResMed Inc. (RMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ResMed Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 27.02x | 26.92x | 35.73x | 39.28x | 75.49x | 44.58x |
| P/B Ratio | 6.34x | 5.65x | 7.76x | 9.11x | 12.41x | 11.10x |
| P/S Ratio | 7.36x | 5.87x | 7.59x | 8.56x | 11.21x | 9.37x |
| Profitability | ||||||
| Gross Margin | 59.4% | 56.7% | 55.8% | 56.6% | 57.5% | 58.1% |
| Operating Margin | 32.7% | 28.2% | 26.8% | 28.0% | 28.3% | 27.4% |
| Net Margin | 27.2% | 21.8% | 21.3% | 21.8% | 14.8% | 21.0% |
| EBITDA Margin | 37.2% | 32.7% | 32.2% | 32.9% | 34.5% | 33.5% |
| Liquidity | ||||||
| Current Ratio | 3.44x | 2.59x | 3.12x | 2.80x | 1.73x | 2.53x |
| Quick Ratio | 2.53x | 1.69x | 1.81x | 1.72x | 1.23x | 1.84x |
| Leverage | ||||||
| Debt/Equity | 0.14x | 0.18x | 0.38x | 0.27x | 0.28x | 0.52x |
YoY = year-over-year change. Source: FMP..